CMMB
Chemomab Therapeutics Ltd DRC
NASDAQ: CMMB · HEALTHCARE · BIOTECHNOLOGY
$1.47
+0.68% today
Updated 2026-04-30
Market cap
$11.59M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.44
Dividend yield
—
52W range
$1 – $6
Volume
0.1M
Chemomab Therapeutics Ltd DRC (CMMB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-69.50%
ROA
-38.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2008 | — | $-2.97M | — | — | — |
| 2009 | — | $-6.82M | — | — | — |
| 2010 | — | $-584000.00 | — | — | — |
| 2011 | — | $-5.99M | — | — | — |
| 2012 | — | $24.18M | — | — | — |
| 2013 | — | $-5.83M | — | — | — |
| 2014 | — | $-6.00M | — | — | — |
| 2015 | — | $-7.50M | — | — | — |
| 2016 | — | $-4.73M | — | — | — |
| 2017 | $0.00 | $-9.81M | — | — | — |
| 2018 | $0.00 | $13.28M | — | — | — |
| 2019 | $0.00 | $27.12M | — | — | — |
| 2020 | $0.00 | $-5.95M | — | — | — |
| 2021 | $0.00 | $-12.48M | — | — | — |
| 2022 | $0.00 | $-27.65M | — | — | — |
| 2023 | $0.00 | $-24.22M | — | — | — |
| 2024 | $0.00 | $-13.95M | — | — | — |
| 2025 | $0.00 | $-9.07M | — | — | — |